Literature DB >> 2186912

Results of screening for verocytotoxin-producing Escherichia coli in faeces in Belgium.

D Piérard1, R Van Etterijck, J Breynaert, L Moriau, S Lauwers.   

Abstract

During an 18-month period all stools submitted to a microbiology laboratory in Belgium for culture were screened for Verocytotoxin-producing Escherichia coli (VTEC) serotype O157. In the stool samples from 3940 patients, eight (0.2%) VTEC O157 strains were isolated, seven of which were O157:H7. Additional screening for other serotypes of VTEC in 332 selected stool samples yielded four more strains (serotypes O2:K1:H6, O111:H-, O117:K1:H7 and O"C70/86":H-). The 0.3% isolation rate for all VTEC was comparable to that for Shigella spp. Eight children under 30 months and two adults suffered from uncomplicated gastroenteritis. A 5-month-old child and a 41-year-old woman presented with hemolytic uremic syndrome a few days after onset of a diarrheal episode.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186912     DOI: 10.1007/bf01963837

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands.

Authors:  C M Taylor; R H White; M H Winterborn; B Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

2.  Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada.

Authors:  W M Johnson; H Lior; G S Bezanson
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

3.  Haemorrhagic colitis and verotoxin-producing Escherichia coli O157 in Belgium.

Authors:  G Robaeys; I Surmont; P Lemmens; G Coremans; G Vantrappen; J Vandepitte
Journal:  Lancet       Date:  1987-06-27       Impact factor: 79.321

4.  First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK.

Authors:  G M Morgan; C Newman; S R Palmer; J B Allen; W Shepherd; A M Rampling; R E Warren; R J Gross; S M Scotland; H R Smith
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

5.  Phage-associated cytotoxin production by and enteroadhesiveness of enteropathogenic Escherichia coli isolated from infants with diarrhea in West Germany.

Authors:  H Karch; J Heesemann; R Laufs
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

6.  Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis.

Authors:  C A Bopp; K D Greene; F P Downes; E G Sowers; J G Wells; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

7.  Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis.

Authors:  S B March; S Ratnam
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

8.  Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes.

Authors:  S M Scotland; B Rowe; H R Smith; G A Willshaw; R J Gross
Journal:  J Med Microbiol       Date:  1988-04       Impact factor: 2.472

9.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more
  12 in total

1.  Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli.

Authors:  T J Novicki; J A Daly; S L Mottice; K C Carroll
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Shiga toxin-producing Escherichia coli in finland from 1990 through 1997: prevalence and characteristics of isolates.

Authors:  M Keskimäki; M Saari; T Heiskanen; A Siitonen
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

3.  Control of enterohaemorrhagic Escherichia coli infection: the need for a network involving microbiological laboratories and clinical and public health institutions.

Authors:  H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

4.  Isolation of verotoxin-producing Escherichia coli O-rough:K1:H7 from two patients with traveler's diarrhea.

Authors:  J Vila; M Vargas; J Ruiz; F Gallardo; M T Jimenez de Anta; J Gascón
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 5.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.

Authors:  K Ramotar; E Henderson; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Comparison of a direct fecal Shiga-like toxin assay and sorbitol-MacConkey agar culture for laboratory diagnosis of enterohemorrhagic Escherichia coli infection.

Authors:  M Ritchie; S Partington; J Jessop; M T Kelly
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

8.  Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates.

Authors:  D Piérard; G Muyldermans; L Moriau; D Stevens; S Lauwers
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

Review 9.  Estimating the burden of foodborne diseases in Japan.

Authors:  Yuko Kumagai; Stuart Gilmour; Erika Ota; Yoshika Momose; Toshiro Onishi; Ver Luanni Feliciano Bilano; Fumiko Kasuga; Tsutomu Sekizaki; Kenji Shibuya
Journal:  Bull World Health Organ       Date:  2015-06-01       Impact factor: 9.408

10.  Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis in Escherichia coli O2:H6.

Authors:  Martina Bielaszewska; Roswitha Schiller; Lydia Lammers; Andreas Bauwens; Angelika Fruth; Barbara Middendorf; M Alexander Schmidt; Phillip I Tarr; Ulrich Dobrindt; Helge Karch; Alexander Mellmann
Journal:  EMBO Mol Med       Date:  2014-01-10       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.